Cargando…

Diagnostic relevance of metastatic renal cell carcinoma in the head and neck: An evaluation of 22 cases in 671 patients

PURPOSE: Renal cell carcinoma (RCC) is a malignant tumor that metastasizes early, and patients often present with metastatic disease at the time of diagnosis. The aim of our evaluation was to assess the diagnostic and differential diagnostic relevance of metastatic renal cell carcinoma (RCC) with pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lieder, Anja, Guenzel, Thomas, Lebentrau, Steffen, Schneider, Constanze, Franzen, Achim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Urologia 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433357/ https://www.ncbi.nlm.nih.gov/pubmed/27649110 http://dx.doi.org/10.1590/S1677-5538.IBJU.2015.0665

Ejemplares similares

Merkel Cell Carcinoma of the Head and Neck: Recommendations for Diagnostics and Treatment
por: Müller-Richter, Urs Dietmar Achim, et al.
Publicado: (2017)

Epigenetic-Mediated Downregulation of Zinc Finger Protein 671 (ZNF671) Predicts Poor Prognosis in Multiple Solid Tumors
por: Zhang, Jian, et al.
Publicado: (2019)

Current relevance of hypoxia in head and neck cancer
por: Bredell, Marius G., et al.
Publicado: (2016)

Comprehensive Exome Analysis of Immunocompetent Metastatic Head and Neck Cancer Models Reveals Patient Relevant Landscapes
por: Li, Hui, et al.
Publicado: (2020)

Metastatic disease in head & neck oncology
por: Pisani, Paolo, et al.
Publicado: (2020)

The Tumor Suppressor Role of Zinc Finger Protein 671 (ZNF671) in Multiple Tumors Based on Cancer Single-Cell Sequencing
por: Zhang, Jian, et al.
Publicado: (2019)

Corrigendum: Epigenetic-mediated downregulation of zinc finger protein 671 (ZNF671) predicts poor prognosis in multiple solid tumors
por: Zhang, Jian, et al.
Publicado: (2023)

Corrigendum: The Tumor Suppressor Role of Zinc Finger Protein 671 (ZNF671) in Multiple Tumors Based on Cancer Single-Cell Sequencing
por: Zhang, Jian, et al.
Publicado: (2020)

Immune-relevant aspects of murine models of head and neck cancer
por: Rossa, Carlos, et al.
Publicado: (2019)

Renal Cell Carcinoma in the Head and Neck: Case Presentation of a Patient With a Rare Metastatic Pattern
por: Lenkeit, Christopher, et al.
Publicado: (2020)

MON-671 Embarrassed to Eat: Two Cases of Gustatory Hyperhidrosis
por: Tarar, Omer H, et al.
Publicado: (2020)

A review on the role of miR-671 in human disorders
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2022)

Role of radiotherapy in the treatment of metastatic head and neck cancer
por: Ordoñez, Rafael, et al.
Publicado: (2019)

Re-irradiation for head and neck cancer: outcome and toxicity analysis using a prospective single institution database
por: Scolari, Chiara, et al.
Publicado: (2023)

Diagnostic value of retrospective PET-MRI fusion in head-and-neck cancer
por: Loeffelbein, Denys J, et al.
Publicado: (2014)

The rising incidence of parotid metastases: our experience from four decades of parotid gland surgery
por: Franzen, A., et al.
Publicado: (2017)

Our experience with optical diagnostics of the head and neck
por: Hopper, Colin, et al.
Publicado: (2010)

Aesthetic Units and Zones of Adherence: Relevance to Surgical Planning in the Head and Neck
por: Kirwan, Laurence
Publicado: (2023)

671. Same Day Identification of Enterobacteriaceae Directly from Urine Samples
por: Kon, Shelley E, et al.
Publicado: (2020)

The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer
por: Tejani, Mohamedtaki A, et al.
Publicado: (2010)

Treatment of Recurrent Metastatic Head and Neck Cancer: Focus on Cetuximab
por: Patel, Akshar N., et al.
Publicado: (2012)

Vitiligoid hypopigmentation associated with pembrolizumab in metastatic head and neck cancer
por: Bulbul, Ajaz
Publicado: (2019)

Osteopontin Levels in Patients with Squamous Metastatic Head and Neck Cancer
por: Maleš, Josip, et al.
Publicado: (2021)

Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
por: Hsieh, Ronan W., et al.
Publicado: (2021)

Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck
por: Pivot, X, et al.
Publicado: (2001)

Diagnostic Value of Diffusion Weighted Magnetic Resonance Imaging in Evaluation of Metastatic Neck Lymph Nodes in Head and Neck Cancer: A Sample of Iranian Patient
por: Alamolhoda, Fatemeh, et al.
Publicado: (2019)

Head & neck optical diagnostics: vision of the future of surgery
por: Upile, Tahwinder, et al.
Publicado: (2009)

Diagnostic Utility of Radiomics in Thyroid and Head and Neck Cancers
por: Gul, Maryam, et al.
Publicado: (2021)

Commentary: Kappen S, Jürgens V, Freitag MH, Winter A. Attitudes Toward and Use of Prostate-Specific Antigen Testing Among Urologists and General Practitioners in Germany: A Survey
por: Braun, Kay-Patrick, et al.
Publicado: (2022)

Immune Escape Mechanisms and Their Clinical Relevance in Head and Neck Squamous Cell Carcinoma
por: Seliger, Barbara, et al.
Publicado: (2020)

Draft Genome Sequence of Pasteurella multocida A:3 Strain 671/90
por: Lainson, Frederick A., et al.
Publicado: (2013)

Head and Neck Metastatic Tumors: a Retrospective Survey of Iranian Patients
por: Sadri, Donia, et al.
Publicado: (2015)

Challenges in Combining Immunotherapy with Radiotherapy in Recurrent/Metastatic Head and Neck Cancer
por: Plavc, Gaber, et al.
Publicado: (2020)

Outcome of Targeted Therapy Recommendations for Metastatic and Recurrent Head and Neck Cancers
por: Taghizadeh, Hossein, et al.
Publicado: (2020)

Potential of Pembrolizumab in Metastatic or Recurrent Head and Neck Cancer: Evidence to Date
por: McCusker, Michael G, et al.
Publicado: (2020)

Identification of acquired Notch3 dependency in metastatic Head and Neck Cancer
por: Kondratyev, Maria, et al.
Publicado: (2023)

Epidermal growth factor receptor variant III in head and neck squamous cell carcinoma is not relevant for targeted therapy and irradiation
por: Koch, Dominik Thomas, et al.
Publicado: (2017)

Novel Diagnostic Approaches for Assessment of the Clinically Negative Neck in Head and Neck Cancer Patients
por: Driessen, Daphne A. J. J., et al.
Publicado: (2021)

Treatment Stratification in First-Line Recurrent or Metastatic Head and Neck Cancer, on Behalf of the EORTC Young Investigator Head and Neck Cancer Group
por: Klinghammer, Konrad, et al.
Publicado: (2022)

The utility of molecular diagnostics to predict recurrence of head and neck carcinoma
por: Pena Murillo, C, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_lhs86ia3mt90sopspegtufamfe